Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease

Medical University of Warsaw

Status: Completed

Conditions: Diphtheria; Inflammatory Bowel Diseases

Treatments: Biological: Diphtheria booster vaccination

Study type: Interventional

Funder types: Other

Identifiers

NCT03998215

Dembinski2012

Details and patient eligibility

About

Assessment of the immunogenicity and safety of booster immunization against diphtheria in children with inflammatory bowel disease.

Enrollment: 46 patients

Sex: All

Ages: 11 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of Crohn's disease or ulcerative colitis based on standard clinical, endoscopic, histologic and radiographic criteria (Porto criteria),
• vaccination, as a part of the basic vaccination course, with five doses of diphtheria, tetanus and whole-cell pertussis vaccine, without booster dose after the age of 6,
• written consent of the patient's legal guardians and the patient himself if he/she turns 16 years of age.

Exclusion criteria

• serious exacerbation of inflammatory bowel disease defined as Paediatric Ulcerative Colitis Activity Index (PUCAI) > 65 points for patients with ulcerative colitis or Pediatric Crohn's Disease Activity Index (PCDAI) > 40 points for patients with Crohn's disease.

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

46 participants in 1 patient group

Diphtheria booster vaccination

Experimental group

Description:

One booster dose of the trivalent vaccine against diphtheria, tetanus and acellular pertussis

Treatment:

Biological: Diphtheria booster vaccination